Cronos Group Inc
TSX:CRON
Intrinsic Value
Cronos Group, Inc. engages in the production and distribution of cannabis. [ Read More ]
The intrinsic value of one
CRON
stock under the Base Case scenario is
0.85
CAD.
Compared to the current market price of 3.64 CAD,
Cronos Group Inc
is
Overvalued by 77%.
CRON's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
CRON or that its price is influenced by factors unrelated to fundamentals.
Cronos Group Inc's market capitalization is 1.4B CAD.
CRON stock price is 3.64 CAD.
CRON stock (0.85 CAD) is 77% less than its price (3.64 CAD).
CRON stock (0.68 CAD) is 81% less than its price (3.64 CAD). Open Relative Valuation
CRON has upside potential of 4% compared to the average analyst price target.
Open Wall St Estimates
CRON's Revenue has grown by 1% over the past 12 months.
CRON's ROIC (Return on Invested Capital) has increased in the last 3 years from -29% to -26%, and is approaching profitability.
CRON's Revenue is forecast to grow at a rate of 17% per year over the next 3 years.
CRON's ROE (Return on Equity) has significantly increased in the last 3 years from -19% to -7%, and is approaching profitability.
CRON's ROE (Return on Equity) for the past 12 months is negative and is equal to -7%.
CRON's Revenue has been growing by an exceptional 23% per year for the last 3 years.
CRON has negative Operating Income for the last twelve months.
CRON has negative Net Income for the last twelve months.
CRON's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -26%.
CRON has positive Gross Profit for the last twelve months.
CRON has negative Free Cash Flow for the last twelve months.
CRON has negative three-year average ROE (Return on Equity): -15%. The company is not efficient at transforming stockholders' equity into net income.
CRON has negative three-year average ROIC (Return on Invested Capital): -35%. The company is not efficient at using invested capital to generate operating income.
CRON's short-term assets (933m USD) exceed its short-term liabilties (41m USD).
CRON's long-term assets (1B USD) exceed its long-term liabilties (41m USD).
CRON's D/E (Debt to Equity) is very low and is equal to 0.
CRON's Altman Z-Score is very high and is equal to 16.03.
Valuation Backtest
Cronos Group Inc
Run backtest to discover the historical profit from buying and selling
CRON
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Cronos Group Inc
Balance Sheet Decomposition
Cronos Group Inc
| Current Assets | 933.3m |
| Cash & Short-Term Investments | 861.5m |
| Receivables | 35.9m |
| Other Current Assets | 35.9m |
| Non-Current Assets | 206.8m |
| Long-Term Investments | 54.7m |
| PP&E | 60.8m |
| Intangibles | 22.1m |
| Other Non-Current Assets | 69.1m |
| Current Liabilities | 41.4m |
| Accounts Payable | 12.1m |
| Accrued Liabilities | 28.7m |
| Other Current Liabilities | 539k |
| Non-Current Liabilities | -885k |
| Other Non-Current Liabilities | -885k |
Earnings Waterfall
Cronos Group Inc
|
Revenue
|
87.2m
USD
|
|
Cost of Revenue
|
-75.3m
USD
|
|
Gross Profit
|
11.9m
USD
|
|
Operating Expenses
|
-91.8m
USD
|
|
Operating Income
|
-79.9m
USD
|
|
Other Expenses
|
5.9m
USD
|
|
Net Income
|
-74m
USD
|
Free Cash Flow Analysis
Cronos Group Inc
CRON Profitability Score
Profitability Due Diligence
Cronos Group Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Cronos Group Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
CRON Solvency Score
Solvency Due Diligence
Cronos Group Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Cronos Group Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRON Price Targets Summary
Cronos Group Inc
According to Wall Street analysts, the average 1-year price target for
CRON
is 3.77 CAD
with a low forecast of 2.87 CAD and a high forecast of 5.25 CAD.
Shareholder Return
CRON Price
Cronos Group Inc
| Average Annual Return | -33.81% |
| Standard Deviation of Annual Returns | 25.22% |
| Max Drawdown | -91% |
| Market Capitalization | 1.4B CAD |
| Shares Outstanding | 381 299 000 |
| Percentage of Shares Shorted | 2.74% |
CRON News
Last Important Events
Cronos Group Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Cronos Group Inc
Company Profile
Cronos Group Inc
Country
Industry
Market Cap
Dividend Yield
Description
Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.
Contact
IPO
Employees
Officers
The intrinsic value of one
CRON
stock under the Base Case scenario is
0.85
CAD.
Compared to the current market price of 3.64 CAD,
Cronos Group Inc
is
Overvalued by 77%.
You don't have any saved screeners yet
